SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

HLC-100 Fully Automated HbA1c Analyzer

Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.

hs cTnI Rapid Quantitative Test

cTnI, a crucial cardiac biomarker, assists in detecting and managing acute myocardial infarction and assessing patient risk in cardiovascular events. Biotime's hs-cTnI offers high sensitivity, compatibility with versatile samples, and stable performance. Trust our ideal biomarker for comprehensive acute coronary syndrome evaluation.

SAA Rapid Quantitative Test

Serum amyloid A (SAA) is a major acute phase protein in human beings, and dogs. The level of SAA proteins in blood increases within just a few hours following the onset of various inflammatory stimuli. These include infection, trauma and surgery

NT-proBNP Rapid Quantitative Test (Chemiluminescence Immunoassay)

NT-proBNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the N-terminal pro-B-type natriuretic peptide（NT-proBNP） concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

BNP Rapid Quantitative Test

During heart failure, the heart makes two proteins, called B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NT-proBNP). Levels of both in the blood go up when heart failure gets worse and go down when it gets better.

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.

HSV-1 IgG/IgM Rapid Test (Fluorescence Immunoassay)

The HSV-1 IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies to HSV1 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. HSV-1 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses 1 (HSV-1) infection -For in vitro diagnostic use only. For professional use only.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A